A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.
about
A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A cost-effectiveness analysis ...... d avert infant adverse events.
@en
A cost-effectiveness analysis ...... d avert infant adverse events.
@nl
type
label
A cost-effectiveness analysis ...... d avert infant adverse events.
@en
A cost-effectiveness analysis ...... d avert infant adverse events.
@nl
prefLabel
A cost-effectiveness analysis ...... d avert infant adverse events.
@en
A cost-effectiveness analysis ...... d avert infant adverse events.
@nl
P2093
P2860
P356
P1476
A cost-effectiveness analysis ...... d avert infant adverse events.
@en
P2093
P2860
P2888
P304
P356
10.1038/TPJ.2017.33
P50
P577
2017-07-11T00:00:00Z
P6179
1090587370